These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1972893)

  • 41. Evidence that 5-HT2 receptors mediate the pressor effect of 8-OH-DPAT in the spinally pithed rat.
    Deckert V; Chaouloff F; Richer C; Elghozi JL
    Arch Int Pharmacodyn Ther; 1990; 306():114-29. PubMed ID: 1981665
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of the lateral tegmental field in the central sympatho-inhibitory effect of 8-hydroxy-2-(di-n-propylamino)tetralin in the cat.
    Vayssettes-Courchay C; offysset F; Verbeuren TJ; Laubie M
    Eur J Pharmacol; 1993 May; 236(1):121-30. PubMed ID: 8319737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urapidil analogues are potent ligands of the 5-HT1A receptor.
    Gross G; Schüttler K; Xin X; Hanft G
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S8-16. PubMed ID: 1702491
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). A model of presynaptic 5-HT1 function.
    Goodwin GM; De Souza RJ; Green AR
    Neuropharmacology; 1985 Dec; 24(12):1187-94. PubMed ID: 2869435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discrete localization of high-density 5-HT1A binding sites in the midline raphe and parapyramidal region of the ventral medulla oblongata of the rat.
    Thor KB; Blitz-Siebert A; Helke CJ
    Neurosci Lett; 1990 Jan; 108(3):249-54. PubMed ID: 2137565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hyperinsulinemia of the genetically obese (fa/fa) rat is decreased by a low dose of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Chaouloff F; Jeanrenaud B
    Eur J Pharmacol; 1988 Feb; 147(1):111-8. PubMed ID: 2967189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence that 5-HT1A receptors are involved in the adrenaline-releasing effects of 8-OH-DPAT in the conscious rat.
    Chaouloff F; Baudrie V; Laude D
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Apr; 341(4):381-4. PubMed ID: 1970616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigation of the mechanism(s) of 8-OH-DPAT-mediated inhibition of plasma insulin in spontaneously hypertensive rats.
    Bouhelal R; Loubatières-Mariani MM; Mir AK
    Br J Pharmacol; 1990 May; 100(1):173-9. PubMed ID: 2142614
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiovascular effects in the Sprague-Dawley rat of 8-hydroxy-2(di-N-propylamino) tetralin, a selective 5-hydroxytryptamine receptor agonist.
    Gradin K; Pettersson A; Hjorth S; Hedner T; Arvidsson LE; Persson B
    J Pharm Pharmacol; 1985 Apr; 37(4):263-5. PubMed ID: 2860226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investigation of mechanisms mediating 8-OH-DPAT-induced impairment of spatial memory: involvement of 5-HT1A receptors in the dorsal hippocampus in rats.
    Egashira N; Yano A; Ishigami N; Mishima K; Iwasaki K; Fujioka M; Matsushita M; Nishimura R; Fujiwara M
    Brain Res; 2006 Jan; 1069(1):54-62. PubMed ID: 16386718
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence that the putative 5-HT1A receptor agonists, 8-OH-DPAT and ipsapirone, have a central hypotensive action that differs from that of clonidine in anaesthetised cats.
    Ramage AG; Fozard JR
    Eur J Pharmacol; 1987 Jun; 138(2):179-91. PubMed ID: 2957220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterogeneity of alpha 2-adrenoceptors in rat cortex but not human platelets can be defined by 8-OH-DPAT, RU 24969 and methysergide.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Mar; 99(3):481-6. PubMed ID: 1970497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alpha 1-adrenoceptor blockade and/or 5-HT1A agonism during treadmill exercise in dogs.
    Grohs JG; Fischer G; Huber S; Raberger G
    J Auton Pharmacol; 1991 Apr; 11(2):101-7. PubMed ID: 1675216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NAN-190: an arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Glennon RA; Naiman NA; Pierson ME; Titeler M; Lyon RA; Weisberg E
    Eur J Pharmacol; 1988 Sep; 154(3):339-41. PubMed ID: 2976673
    [No Abstract]   [Full Text] [Related]  

  • 55. 8-OH-DPAT, flesinoxan and guanfacine: systemic and regional haemodynamic effects of centrally acting antihypertensive agents in anaesthetized rabbits.
    Hof RP; Fozard JR
    Br J Pharmacol; 1989 Apr; 96(4):864-71. PubMed ID: 2568144
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pentobarbital anaesthesia prevents the adrenaline-releasing effect of the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino) tetralin.
    Chaouloff F; Baudrie V; Laude D
    Eur J Pharmacol; 1990 May; 180(1):175-8. PubMed ID: 2142092
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat.
    Calogero AE; Bagdy G; Szemeredi K; Tartaglia ME; Gold PW; Chrousos GP
    Endocrinology; 1990 Apr; 126(4):1888-94. PubMed ID: 2156670
    [TBL] [Abstract][Full Text] [Related]  

  • 58. BMY 7378 is an agonist at 5-HT1A receptors mediating hypotension and renal sympatho-inhibition in anaesthetised cats.
    Stubbs CM; Connor HE; Feniuk W
    Eur J Pharmacol; 1991 May; 197(1):113-6. PubMed ID: 1832639
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conditioned reinforcing effects of 8-hydroxy-2-(di-N-propylamino) tetralin: involvement of 5-hydroxytryptamine 1A and D1 dopamine receptors.
    Shippenberg TS
    Neurosci Lett; 1991 Jan; 121(1-2):136-8. PubMed ID: 1826942
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function.
    Gillis RA; Hill KJ; Kirby JS; Quest JA; Hamosh P; Norman WP; Kellar KJ
    J Pharmacol Exp Ther; 1989 Feb; 248(2):851-7. PubMed ID: 2521902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.